Search results
Why Is AstraZeneca Stock Trading Lower On Tuesday?
Benzinga via Yahoo Finance· 2 hours agoOn Tuesday, AstraZeneca Plc (NASDAQ:AZN) said the survival results did not reach statistical significance in the overall trial population in the...
AstraZeneca-Daiichi's Enhertu follow-up unable to prove overall survival benefit in phase 3
FierceBiotech· 11 hours agoDaiichi Sankyo and antibody-drug conjugate (ADC) partner AstraZeneca have already filed their...
JPMorgan bullish on AstraZeneca stock, highlights AZD0780's sales By Investing.com
Investing.com· 11 hours agoOn Tuesday, JPMorgan (NYSE:JPM) maintained its positive stance on AstraZeneca (NASDAQ:AZN:LN)...
Here's Why We Think AstraZeneca (LON:AZN) Is Well Worth Watching
Simply Wall St. via Yahoo Finance· 4 days agoIf this kind of company isn't your style, you like companies that generate revenue, and even earn...
AstraZeneca and Daiichi Sankyo’s ADC improves survival in NSCLC trial
Clinical Trials Arena via Yahoo Finance· 1 day agoAstraZeneca and Daiichi Sankyo have reported high-level overall survival (OS) results from the Phase...
AstraZeneca PLC (NASDAQ:AZN) Shares Acquired by Kingsview Wealth Management LLC
ETF DAILY NEWS· 7 days agoKingsview Wealth Management LLC grew its stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 11.3% during the 4th quarter, according to the company in its most recent disclosure ...
Here's Why Astrazeneca (AZN) is a Strong Growth Stock
Zacks via Yahoo Finance· 1 day agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
AstraZeneca, Daiichi Sankyo's Experimental Lung Cancer Drug Shows Improvement in Patients
Market Watch· 1 day agoAstraZeneca said its experimental drug for non-small cell lung cancer, jointly developed with Japan's Daiichi Sankyo, showed improvement in progression-free survival in its ...
Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
Zacks via Yahoo Finance· 4 days agoAstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer...
AstraZeneca and Nona Biosciences sign agreement for monoclonal antibody
Pharmaceutical Technology via Yahoo Finance· 5 days agoAstraZeneca has entered a worldwide licence and option agreement with Nona Biosciences for a...